Page last updated: 2024-10-30

mebendazole and Epithelial Ovarian Cancer

mebendazole has been researched along with Epithelial Ovarian Cancer in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Ovarian cancer is the third most common cancer and the second most common cause of gynecologic cancer death in women."1.62Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways. ( Chen, C; Haydon, RC; He, F; He, TC; Huang, L; Liu, Q; Luu, HH; Ni, N; Reid, RR; Shen, L; Shi, D; Tang, L; Wagstaff, W; Wang, H; Zhang, J; Zhao, L, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Huang, L1
Zhao, L1
Zhang, J1
He, F1
Wang, H1
Liu, Q1
Shi, D1
Ni, N1
Wagstaff, W1
Chen, C1
Reid, RR1
Haydon, RC1
Luu, HH1
Shen, L1
He, TC1
Tang, L1

Other Studies

1 other study available for mebendazole and Epithelial Ovarian Cancer

ArticleYear
Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways.
    Aging, 2021, 07-07, Volume: 13, Issue:13

    Topics: Animals; Antinematodal Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Ovarian Epithelial; Cell

2021